AAAAAA

   
Results: 1-16 |
Results: 16
TREATMENT OF METASTATIC OSTEOSARCOMA AT DIAGNOSIS - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: HARRIS MB GIESER P GOORIN AM AYALA A SHOCHAT SJ FERGUSON WS HOLBROOK T LINK MP
Citation: Mb. Harris et al., TREATMENT OF METASTATIC OSTEOSARCOMA AT DIAGNOSIS - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 16(11), 1998, pp. 3641-3648
RISK-FACTORS FOR EARLY ANTHRACYCLINE CLINICAL CARDIOTOXICITY IN CHILDREN - THE PEDIATRIC-ONCOLOGY-GROUP EXPERIENCE
Authors: KRISCHER JP CUTHBERTSON DD EPSTEIN S GOORIN AM EPSTEIN ML LIPSHULTZ SE
Citation: Jp. Krischer et al., RISK-FACTORS FOR EARLY ANTHRACYCLINE CLINICAL CARDIOTOXICITY IN CHILDREN - THE PEDIATRIC-ONCOLOGY-GROUP EXPERIENCE, Progress in pediatric cardiology, 8(2), 1997, pp. 83-90
CLINICAL CARDIOTOXICITY FOLLOWING ANTHRACYCLINE TREATMENT FOR CHILDHOOD-CANCER - THE PEDIATRIC-ONCOLOGY-GROUP EXPERIENCE
Authors: KRISCHER JP EPSTEIN S CUTHBERTSON DD GOORIN AM EPSTEIN ML LIPSHULTZ SE
Citation: Jp. Krischer et al., CLINICAL CARDIOTOXICITY FOLLOWING ANTHRACYCLINE TREATMENT FOR CHILDHOOD-CANCER - THE PEDIATRIC-ONCOLOGY-GROUP EXPERIENCE, Journal of clinical oncology, 15(4), 1997, pp. 1544-1552
METHOTREXATE OSTEOPATHY IN PATIENTS WITH OSTEOSARCOMA
Authors: ECKLUND K LAOR T GOORIN AM CONNOLLY LP JARAMILLO D
Citation: K. Ecklund et al., METHOTREXATE OSTEOPATHY IN PATIENTS WITH OSTEOSARCOMA, Radiology, 202(2), 1997, pp. 543-547
IFOSFAMIDE CARBOPLATIN ETOPOSIDE (ICE) FOR RECURRENT MALIGNANT SOLID TUMORS OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP PHASE I II STUDY/
Authors: KUNG FH DESAI SJ DICKERMAN JD GOORIN AM HARRIS MB INOUE S KRISCHER JP MURPHY SB PRATT CB TOLEDANO S WILEY JM YU AL
Citation: Fh. Kung et al., IFOSFAMIDE CARBOPLATIN ETOPOSIDE (ICE) FOR RECURRENT MALIGNANT SOLID TUMORS OF CHILDHOOD - A PEDIATRIC-ONCOLOGY-GROUP PHASE I II STUDY/, Journal of pediatric hematology/oncology, 17(3), 1995, pp. 265-269
TREATMENT OF OSTEOSARCOMA WITH IFOSFAMIDE - COMPARISON OF RESPONSE INPEDIATRIC-PATIENTS WITH RECURRENT DISEASE VERSUS PATIENTS PREVIOUSLY UNTREATED - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: HARRIS MB CANTOR AB GOORIN AM SHOCHAT SJ AYALA AG FERGUSON WS HOLBROOK T LINK MP
Citation: Mb. Harris et al., TREATMENT OF OSTEOSARCOMA WITH IFOSFAMIDE - COMPARISON OF RESPONSE INPEDIATRIC-PATIENTS WITH RECURRENT DISEASE VERSUS PATIENTS PREVIOUSLY UNTREATED - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Medical and pediatric oncology, 24(2), 1995, pp. 87-92
METHOTREXATE OSTEOPATHY IN PATIENTS WITH OSTEOSARCOMA
Authors: ECKLUND K LAOR T GOORIN AM CONNOLLY LP JARAMILLO D
Citation: K. Ecklund et al., METHOTREXATE OSTEOPATHY IN PATIENTS WITH OSTEOSARCOMA, Radiology, 197, 1995, pp. 363-363
FEMALE SEX AND HIGHER DRUG DOSE AS RISK-FACTORS FOR LATE CARDIOTOXIC EFFECTS OF DOXORUBICIN THERAPY FOR CHILDHOOD-CANCER
Authors: LIPSHULTZ SE LIPSITZ SR MONE SM GOORIN AM SALLAN SE SANDERS SP ORAV EJ GELBER RD COLAN SD
Citation: Se. Lipshultz et al., FEMALE SEX AND HIGHER DRUG DOSE AS RISK-FACTORS FOR LATE CARDIOTOXIC EFFECTS OF DOXORUBICIN THERAPY FOR CHILDHOOD-CANCER, The New England journal of medicine, 332(26), 1995, pp. 1738-1743
LATE CARDIOTOXICITY FOLLOWING CHILDHOOD MALIGNANCY - THE EFFECTS OF GENDER AND DOXORUBICIN DOSE
Authors: LIPSHULTZ SE LIPSITZ S MONE SM GOORIN AM SALLAN SE SANDERS SP COLAN SD
Citation: Se. Lipshultz et al., LATE CARDIOTOXICITY FOLLOWING CHILDHOOD MALIGNANCY - THE EFFECTS OF GENDER AND DOXORUBICIN DOSE, Journal of the American College of Cardiology, 1994, pp. 10000120-10000120
SECONDARY BREAST-CANCER IN PATIENTS PRESENTING WITH OSTEOSARCOMA - POSSIBLE INVOLVEMENT OF GERMLINE P53 MUTATIONS
Authors: RUSSO CL MCINTYRE J GOORIN AM LINK MP GEBHARDT MC FRIEND SH
Citation: Cl. Russo et al., SECONDARY BREAST-CANCER IN PATIENTS PRESENTING WITH OSTEOSARCOMA - POSSIBLE INVOLVEMENT OF GERMLINE P53 MUTATIONS, Medical and pediatric oncology, 23(4), 1994, pp. 354-358
THE ANTHRACYCLINE CARDIOTOXICITY DEBATE - IN REPLY
Authors: LIPSHULTZ SE SANDERS SP COLAN SD GOORIN AM SALLAN SE KRISCHER JP
Citation: Se. Lipshultz et al., THE ANTHRACYCLINE CARDIOTOXICITY DEBATE - IN REPLY, Pediatrics, 94(5), 1994, pp. 781-782
THE ANTHRACYCLINE CARDIOTOXICITY DEBATE - IN REPLY
Authors: LIPSHULTZ SE SANDERS SP COLAN SD GOORIN AM SALLAN SE KRISCHER JP
Citation: Se. Lipshultz et al., THE ANTHRACYCLINE CARDIOTOXICITY DEBATE - IN REPLY, Pediatrics, 94(5), 1994, pp. 781-782
MONITORING FOR ANTHRACYCLINE CARDIOTOXICITY
Authors: LIPSHULTZ SE SANDERS SP GOORIN AM KRISCHER JP SALLAN SE COLAN SD
Citation: Se. Lipshultz et al., MONITORING FOR ANTHRACYCLINE CARDIOTOXICITY, Pediatrics, 93(3), 1994, pp. 433-437
ANTHRACYCLINE CARDIOTOXICITY IN CHILDREN WITH CANCER
Authors: CUTHBERTSON DD EPSTEIN ST LIPSHULTZ SE GOORIN AM EPSTEIN ML KRISCHER JP
Citation: Dd. Cuthbertson et al., ANTHRACYCLINE CARDIOTOXICITY IN CHILDREN WITH CANCER, Circulation, 90(4), 1994, pp. 50-50
ANTHRACYCLINE CARDIOTOXICITY IN CHILDREN WITH CANCER
Authors: CUTHBERTSON DD EPSTEIN ST LIPSHULTZ SE GOORIN AM EPSTEIN ML KRISCHER JP
Citation: Dd. Cuthbertson et al., ANTHRACYCLINE CARDIOTOXICITY IN CHILDREN WITH CANCER, Circulation, 90(4), 1994, pp. 50-50
LONG-TERM PULMONARY TOXICITY OF MULTIAGENT CHEMOTHERAPY INCLUDING BLEOMYCIN AND CYCLOPHOSPHAMIDE IN OSTEOSARCOMA SURVIVORS
Authors: KHARASCH VS SANTIS WF HALLOWELL J LIPSITZ S GOORIN AM
Citation: Vs. Kharasch et al., LONG-TERM PULMONARY TOXICITY OF MULTIAGENT CHEMOTHERAPY INCLUDING BLEOMYCIN AND CYCLOPHOSPHAMIDE IN OSTEOSARCOMA SURVIVORS, The American review of respiratory disease, 147(4), 1993, pp. 87-87
Risultati: 1-16 |